Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the Congo.
Choi EM, Kasonia K, Kavunga-Membo H, Mukadi-Bamuleka D, Soumah A, Mossoko Z, Edwards T, Tetsa-Tata D, Makarimi R, Toure O, Mambula G, Brindle H, Camacho A, Connor NE, Mukadi P, McLean C, Keshinro B, Gaddah A, Robinson C, Luhn K, Foster J, Roberts CH, Johnson JE, Imbault N, Bausch DG, Grais RF, Watson-Jones D, Muyembe-Tamfum JJ; Tujiokowe Study Consortium. Choi EM, et al. Vaccines (Basel). 2024 Jul 23;12(8):828. doi: 10.3390/vaccines12080828. Vaccines (Basel). 2024. PMID: 39203955 Free PMC article.
Delivery and Safety of a Two-Dose Preventive Ebola Virus Disease Vaccine in Pregnant and Non-Pregnant Participants during an Outbreak in the Democratic Republic of the Congo.
Kavunga-Membo H, Watson-Jones D, Kasonia K, Edwards T, Camacho A, Mambula G, Tetsa-Tata D, Choi EM, Aboubacar S, Brindle H, Roberts C, Manno D, Faguer B, Mossoko Z, Mukadi P, Kakule M, Balingene B, Mapendo EK, Makarimi R, Toure O, Campbell P, Mousset M, Nsaibirni R, Ama IS, Janvier KK, Keshinro B, Cissé B, Sahani MK, Johnson J, Connor N, Lees S, Imbault N, Robinson C, Grais RF, Bausch DG, Muyembe-Tamfum JJ. Kavunga-Membo H, et al. Among authors: choi em. Vaccines (Basel). 2024 Jul 23;12(8):825. doi: 10.3390/vaccines12080825. Vaccines (Basel). 2024. PMID: 39203952 Free PMC article.
Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: An updated systematic review of evidence from clinical trials.
Whitworth HS, Mounier-Jack S, Choi EM, Gallagher KE, Howard N, Kelly H, Mbwanji G, Kreimer AR, Basu P, Barnabas R, Drolet M, Brisson M, Watson-Jones D. Whitworth HS, et al. Among authors: choi em. Vaccine X. 2024 Apr 16;19:100486. doi: 10.1016/j.jvacx.2024.100486. eCollection 2024 Aug. Vaccine X. 2024. PMID: 38873638 Free PMC article. Review.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
Choi EM, Lacarra B, Afolabi MO, Ale BM, Baiden F, Bétard C, Foster J, Hamzé B, Schwimmer C, Manno D, D'Ortenzio E, Ishola D, Keita CM, Keshinro B, Njie Y, van Dijck W, Gaddah A, Anumendem D, Lowe B, Vatrinet R, Lawal BJ, Otieno GT, Samai M, Deen GF, Swaray IB, Kamara AB, Kamara MM, Diagne MA, Kowuor D, McLean C, Leigh B, Beavogui AH, Leyssen M, Luhn K, Robinson C, Douoguih M, Greenwood B, Thiébaut R, Watson-Jones D; EBOVAC-3/EBL2005 Study Team. Choi EM, et al. Lancet Glob Health. 2023 Nov;11(11):e1743-e1752. doi: 10.1016/S2214-109X(23)00410-2. Lancet Glob Health. 2023. PMID: 37858585 Free article. Clinical Trial.
249 results